The Urgent Need for Evidence Over Anecdote: Equipoise in the ExTINGUISH Clinical Trial in Anti-NMDAR Encephalitis (P7-8.016)
Assess whether treatment strategies and patient outcomes in anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) have evolved since the last comprehensive review of the literature in January 2019.
Authors
- Susan Flavin (ORCID: https://orcid.org/0000-0002-5587-4552)
- Yoji Hoshina (ORCID: https://orcid.org/0000-0003-0228-664X)
- Albert Aboseif (ORCID: https://orcid.org/0000-0001-5053-8544)
- Αναστασία Ζεκερίδου (ORCID: https://orcid.org/0000-0002-1960-9065)
- Maarten J. Titulaer (ORCID: https://orcid.org/0000-0002-1033-3840)
- Lisa K. Peterson (ORCID: https://orcid.org/0000-0001-8702-1311)
- Melissa A. Wright (ORCID: https://orcid.org/0000-0002-7804-9627)
- Josep Dalmau (ORCID: https://orcid.org/0000-0001-5856-2813)
- Gregory Scott Day (ORCID: https://orcid.org/0000-0001-5133-5538)
- Stacey Lynn Clardy (ORCID: https://orcid.org/0000-0001-6600-9428)
- Ka‐Ho Wong (ORCID: https://orcid.org/0000-0001-9597-8105)
- Brenda Banwell
- Hyun Cho (ORCID: https://orcid.org/0000-0002-2339-2591)
- Annalisa Dialino-Felix
- Christopher S. Coffey
- Tammy Smith
- L.V. Dill
Institutions
- University of Iowa (US)
- Amgen (United States) (US)
- Mayo Clinic (US)
- Children's Hospital of Philadelphia (US)
- University of Utah (US)
- Erasmus MC (NL)
- WinnMed (US)
- ARUP Laboratories (United States) (US)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211728
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00